BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19534712)

  • 1. Oral vaccine delivery--new strategies and technologies.
    Simerska P; Moyle PM; Olive C; Toth I
    Curr Drug Deliv; 2009 Aug; 6(4):347-58. PubMed ID: 19534712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
    O'Hagan DT; Illum L
    Crit Rev Ther Drug Carrier Syst; 1990; 7(1):35-97. PubMed ID: 2257636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting.
    Kang SH; Hong SJ; Lee YK; Cho S
    Polymers (Basel); 2018 Aug; 10(9):. PubMed ID: 30960873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation of oral mucosal vaccines targeting dendritic cells.
    Owen JL; Sahay B; Mohamadzadeh M
    Curr Opin Chem Biol; 2013 Dec; 17(6):918-24. PubMed ID: 23835515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for enhancing oral bioavailability of peptides and proteins.
    Renukuntla J; Vadlapudi AD; Patel A; Boddu SH; Mitra AK
    Int J Pharm; 2013 Apr; 447(1-2):75-93. PubMed ID: 23428883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of oral vaccines].
    Matsubara A; Shimizu Y; Karamatsu K; Yasutomi Y
    Nihon Rinsho; 2008 Oct; 66(10):1873-8. PubMed ID: 18939484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [M cell in vitro model and its application in oral delivery of macromolecular drugs].
    Li HF; Zou J; Bai RY; Xing YM; Nie JM; Diao Y
    Yao Xue Xue Bao; 2011 Dec; 46(12):1429-35. PubMed ID: 22375414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
    Mishra N; Singh D; Sharma S; Baldi A
    Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mucosal immune system for vaccine development.
    Lamichhane A; Azegamia T; Kiyonoa H
    Vaccine; 2014 Nov; 32(49):6711-23. PubMed ID: 25454857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for mucosal vaccine development.
    Boyaka PN; Marinaro M; Vancott JL; Takahashi I; Fujihashi K; Yamamoto M; van Ginkel FW; Jackson RJ; Kiyono H; McGhee JR
    Am J Trop Med Hyg; 1999 Apr; 60(4 Suppl):35-45. PubMed ID: 10344675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of oral tolerance and issues related to oral vaccine design.
    Poonam P
    Curr Pharm Des; 2007; 13(19):2001-7. PubMed ID: 17627533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
    des Rieux A; Fievez V; Garinot M; Schneider YJ; Préat V
    J Control Release; 2006 Nov; 116(1):1-27. PubMed ID: 17050027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunisation: adjuvants and delivery systems.
    Moyle PM; McGeary RP; Blanchfield JT; Toth I
    Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.